ARQT

Arcutis Biotherapeutics

Stock NASDAQ – Stock Market Prices, News & Analysis

Arcutis Biotherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of dermatological treatments.

$ 24.21
1.47 %

Arcutis Biotherapeutics

$ 24.21
1.47 %
ARQT

Arcutis Biotherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of dermatological treatments.

Price history of Arcutis Biotherapeutics
Price history of Arcutis Biotherapeutics

Performance & Momentum

6 Months 18.83 %
1 Year 68.91 %
3 Years 98.95 %
5 Years 7.55 %

Strategic Analysis

Arcutis Biotherapeutics • 2026

Arcutis Biotherapeutics positions itself as a specialized player in the development and commercialization of innovative dermatological treatments, capitalizing on unmet medical needs in the healthcare sector. Its model relies on a targeted biotechnology approach aimed at offering differentiated solutions in a niche segment of dermatology.

Strengths
  • Significant growth potential linked to a portfolio of innovative dermatological treatments
  • Positioning in a therapeutic segment with high regulatory barriers to entry
  • Demonstrated ability to generate strong commercial momentum in the short to medium term
Weaknesses
  • Long-term performance history marked by volatility and notable correction
  • Significant dependence on the clinical and commercial success of its flagship products
Momentum

The momentum is strong, driven by very positive recent performance that reflects increased investor confidence in the development strategy. This dynamic suggests a favorable phase for expansion and positioning in the dermatological market, enhancing the appeal for a growth profile.

Similar stocks to Arcutis Biotherapeutics

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone